Mineralys Therapeutics (MLYS) Treasury Shares (2022 - 2025)

Mineralys Therapeutics (MLYS) has 4 years of Treasury Shares data on file, last reported at $125793.0 in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares fell 66.01% year-over-year to $125793.0; the trailing twelve-month figure through Dec 2025 stood at $125793.0 (down 66.01% YoY), and the FY2025 full-year result was $125793.0, down 66.01% from the prior year.
• Treasury Shares eased to $125793.0 in Q4 2025, from $370106.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $136.5 million in Q2 2022 to a low of $125793.0 in Q4 2025.
• A 4-year average of $60.1 million and a median of $43.7 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 98.83% in 2023 and slumped 63.28% in 2024, its largest moves.
• Tracing MLYS's Treasury Shares over 4 years: stood at $86.3 million in 2022, then sank by 98.83% to $1.0 million in 2023, then tumbled by 63.28% to $370106.0 in 2024, then slumped by 66.01% to $125793.0 in 2025.
• Business Quant data shows MLYS's Treasury Shares at $125793.0 in Q4 2025, $370106.0 in Q4 2024, and $1.0 million in Q4 2023.